4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-24-034671
Director bought 6,860 shares at $7.29 ($50,009)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HENNEMAN JOHN B III Director | 2024-03-13 | Purchase | +6,860 | $7.29 | $50,009 | 8,139 | D |
| Derivatives | |||||||
| HENNEMAN JOHN B III Director | 2024-03-13 | Purchase · Tranche A Warrant | +3,430 | 3,430 | D | ||
| HENNEMAN JOHN B III Director | 2024-03-13 | Purchase · Tranche B Warrant | +3,430 | 3,430 | D | ||
| Open-market purchases · 6,860 sh · avg $7.29 · $50,009 | |||||||
Loading xslF345X05/tm248935-2_4seq1.xml…